+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are evaluating whether reading a personal narrative book can improve emotional regulation and reduce psychological distress in women of childbearing age who are preparing for a hysterectomy due to non-malignant conditions. This trial compares the effects of this approach to standard care, which includes an information leaflet and psychological consultation if needed. The study aims to see if this intervention can reduce catastrophizing, anxiety, and depressive symptoms before surgery and improve patient satisfaction after surgery. Participants will be randomly assigned to receive either the standard care or the standard care plus the personal narrative book. The intervention group will read a book written by a patient who underwent a hysterectomy, in addition to receiving standard information and support. The study period between inclusion and surgery ranges from 1 to 3 months, during which emotional and psychological effects will be monitored. During the study, participants will provide oral informed consent and complete questionnaires assessing their emotional and psychological experiences. Researchers will measure adaptive emotional regulation, anxiety, depression, catastrophizing, use of additional supportive measures, and patient satisfaction both before and after surgery. The study will monitor these outcomes from inclusion until postoperative follow-up occurring within 1 to 3 months, with the primary focus on adaptive regulation between inclusion and surgery.

Age: 18Years - 42YearsFEMALEPhase Not Applicable
4 locations
P

Actively Recruiting

Researchers are investigating whether using a genetic test called Prosigna4 can help decide if chemotherapy is necessary for premenopausal women with hormone receptor-positive HR and HER2-negative breast cancer. This study aims to determine if treatment guided by this test produces similar outcomes to the standard approach of systematic chemotherapy. The trial focuses on younger women who often experience more side effects from chemotherapy, affecting their quality of life and work capacity. Participants will be randomly assigned to one of two groups. In the experimental group, treatment depends on the Prosigna4 score women with a high score above 60 will receive chemotherapy plus hormone therapy, while those with a lower score will receive only hormone therapy with ovarian suppression. The control group will receive the standard treatment of chemotherapy followed by hormone therapy. The study includes a pre-inclusion period for eligibility testing and randomization. Throughout the study, participants will complete questionnaires about quality of life, treatment side effects, emotional well-being, and other health measures for up to five years after randomization. Researchers will monitor cancer recurrence, survival, fertility, osteoporosis, cardiovascular disease, and other outcomes. Regular assessments include physical activity levels, adherence to therapy, and patient perceptions of treatment and participation, aiming to evaluate the safety and impact of treatment guided by the genetic test.

Age: 35Years - 45YearsFEMALEPhase 3
105 locations
O

Actively Recruiting

Researchers are evaluating a remotely supervised online cognitive stimulation program compared to an unsupervised online cognitive exercise program to reduce cognitive complaints in patients treated for localized breast cancer after adjuvant chemotherapy. This study aims to understand if supervision by a neuropsychologist improves the effectiveness of cognitive interventions. Prior studies showed benefits from online programs, and this research explores the added value of personalized support and education during the intervention. The trial includes two groups one receiving a 12-week program with three 20-minute online cognitive sessions weekly plus a 30-minute weekly remote supervision session by a neuropsychologist, and a control group with access to the same online cognitive exercises without supervision. The exercises target up to 12 cognitive areas such as attention, memory, executive functions, and processing speed using the PRESCO program from the HAPPYNeuron-Pro software. Participants will be monitored over 12 weeks, with researchers assessing changes in perceived cognitive impairment using the Functional Assessment of Cancer Therapy-Cognitive Function FACT-Cog questionnaire. The primary outcome is the average change in the Perceived Cognitive Impairment subscale after 12 weeks. The study also evaluates adherence to the program and benefits on objective cognitive impairment. The study is randomized and includes adult female patients who have received chemotherapy and are undergoing radiotherapy.

Age: 18Months +FEMALEPhase Not Applicable
25 locations